Main container

A Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 syst...

Titolo
A Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 syst...
Codice
CL3-95031-007
Tipo
Sperimentale con farmaco
Anno avvio
2025
Stato
In Corso

Sperimentatore principale

Unità operative che promuovono lo studio

Documenti e video allegati

Ti potrebbe interessare anche

Studi clinici
Terapia orientata alla matrice in adolescenti vicini all’età adulta e adulti affetti da osteogenesi imperfetta – studio “MOI-A”
Leggi tutto
Studi clinici
A Multi-Centre Clinical Investigation To Evaluate The Safety And Performance Of The Freedom Total Knee® System With The PEEK-OPTIMA™ Femoral Component
Leggi tutto
Studi clinici
Pediatric Oncological Orthopaedic Reconstructions: analysis of the clinical and radiographic results
Leggi tutto
Contenuto aggiornato il
20/01/2025 17:05